All Stories

  1. Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian centre

    Article • Clinical Endocrinology, May 2017, Wiley

    Dr Warrick J Inder

  2. Thrombospondin-1 is a glucocorticoid responsive protein in humans

    Article • November 2015, Bioscientifica

    Dr Warrick J Inder

  3. The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data

    Article • The Lancet Diabetes & Endocrinology, November 2015, Elsevier

    Dr Warrick J Inder

  4. Exploratory Study of Total and Free Prednisolone Plasma Exposure and Cushingoid Appearance, Quality of Life and Biochemical Toxicity in Adult Male Kidney Transplant Recipients

    Article • Clinical Drug Investigation, September 2015, Springer Science + Business Media

    Dr Warrick J Inder

  5. Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas

    Article • Clinical Endocrinology, September 2015, Wiley

    Dr Warrick J Inder

  6. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2015, Endocrine Society

    Dr Warrick J Inder, Dr Niki Karavitaki, Marta Korbonits

  7. Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise

    Article • PLoS ONE, June 2015, PLOS

    Dr Warrick J Inder, Professor Andre La Gerche

  8. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial

    Article • Psychoneuroendocrinology, June 2015, Elsevier

    Dr Warrick J Inder

  9. Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study

    Article • Phytotherapy Research, April 2015, Wiley

    Dr Warrick J Inder

  10. Rare cause of pituitary apoplexy

    Article • Endocrinology Diabetes and Metabolism Case Reports, February 2015, Bioscientifica

    Dr Warrick J Inder, Dr Stephanie Louise Teasdale

  11. Continuous Subcutaneous Hydrocortisone Infusion Therapy in Addison's Disease: A Randomized, Placebo-Controlled Clinical Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2014, Endocrine Society

    Dr Warrick J Inder

  12. Management of hypertension and heart failure in patients with Addison's disease

    Article • Clinical Endocrinology, September 2014, Wiley

    Dr Warrick J Inder

  13. An Audit of Amiodarone-induced Thyrotoxicosis - do Anti-thyroid Drugs alone Provide Adequate Treatment?

    Article • Heart Lung and Circulation, June 2014, Elsevier

    Dr Warrick J Inder

  14. Effect of a dedicated osteoporosis health professional on screening and treatment in outpatients presenting with acute low trauma non-hip fracture: a systematic review

    Article • Archives of Osteoporosis, January 2014, Springer Science + Business Media

    Dr Warrick J Inder

  15. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers

    Article • BMC Endocrine Disorders, January 2014, Springer Science + Business Media

    Dr Warrick J Inder

  16. Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy

    Article • Pituitary, June 2013, Springer Science + Business Media

    Dr Warrick J Inder

  17. Free and Total Plasma Cortisol Measured by Immunoassay and Mass Spectrometry Following ACTH1–24Stimulation in the Assessment of Pituitary Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2013, Endocrine Society

    Dr Warrick J Inder

  18. Gender differences in presentation and outcome of nonfunctioning pituitary macroadenomas

    Article • Clinical Endocrinology, March 2013, Wiley

    Dr Warrick J Inder

  19. Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications

    Article • Clinical Endocrinology, October 2012, Wiley

    Dr Warrick J Inder

  20. Difficulties in Recruitment for a Randomised Controlled Trial of Lifestyle Intervention for Type 2 Diabetes: Implications for Diabetes Management

    Article • Open Journal of Endocrine and Metabolic Diseases, January 2012, Scientific Research Publishing, Inc,

    Dr Warrick J Inder

  21. Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11β-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes

    Article • Clinical Epigenetics, January 2012, Springer Science + Business Media

    Dr Warrick J Inder

  22. No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome

    Article • The Medical Journal of Australia, November 2011, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Dr Warrick J Inder

  23. Antipsychotic-Induced Hyperprolactinaemia

    Article • Australian & New Zealand Journal of Psychiatry, October 2011, SAGE Publications

    Dr Warrick J Inder

  24. Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle

    Article • Medicine & Science in Sports & Exercise, June 2011, Wolters Kluwer Health

    Professor Andre La Gerche, Dr Warrick J Inder, Professor Andre La Gerche

  25. A Longitudinal Study of Plasma and Urinary Cortisol in Pregnancy and Postpartum

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2011, Endocrine Society

    Dr Warrick J Inder

  26. The 4mg Intravenous Dexamethasone Suppression Test in the Diagnosis of Cushing’s Syndrome

    Article • Clinical Endocrinology, December 2009, Wiley

    Dr Warrick J Inder

  27. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1 - implications for steroid-induced myopathy

    Article • Clinical Endocrinology, August 2009, Wiley

    Dr Warrick J Inder

  28. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone

    Article • Clinical Endocrinology, November 2008, Wiley

    Dr Warrick J Inder

  29. Altered Activity of 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 in Skeletal Muscle Confers Metabolic Protection in Subjects with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2007, Endocrine Society

    Dr Warrick J Inder

  30. 11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle

    Article • Clinical Endocrinology, September 2006, Wiley

    Dr Warrick J Inder

  31. Hyperprolactinaemia – Differential Diagnosis, Investigation and Management

    Article • touchREVIEWS in Endocrinology, January 2006, Touch Digital Media, Ltd.

    Dr Warrick J Inder

  32. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?

    Article • Clinical Endocrinology, October 2005, Wiley

    Dr Warrick J Inder

  33. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment

    Article • Clinical Endocrinology, March 2005, Wiley

    Dr Warrick J Inder

  34. Glucocorticoid Replacement in Pituitary Surgery: Guidelines for Perioperative Assessment and Management

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Dr Warrick J Inder

  35. Plasma corticotropin-releasing hormone and unconjugated estriol in human pregnancy: Gestational patterns and ability to predict preterm delivery

    Article • American Journal of Obstetrics and Gynecology, January 2002, Elsevier

    Dr Warrick J Inder

  36. The Utility of Plasma CRH as a Predictor of Preterm Delivery

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2001, Endocrine Society

    Dr Warrick J Inder

  37. Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine

    Article • Psychopharmacology, June 2001, Springer Science + Business Media

    Dr Warrick J Inder

  38. Activin Effects on Neoplastic Proliferation of Human Pituitary Tumors1

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2000, Endocrine Society

    Dr Warrick J Inder

  39. The effect of glycerol and desmopressin on exercise performance and hydration in triathletes

    Article • Medicine & Science in Sports & Exercise, August 1998, Wolters Kluwer Health

    Dr Warrick J Inder

  40. Diagnosis, monitoring, and management of congenital adrenal hyperplasia

    Article • Current Opinion in Endocrinology and Diabetes, June 1995, Wolters Kluwer Health

    Dr Warrick J Inder

  41. Exercise and the Hypothalamic-Pituitary-Adrenal Axis

    Article • Wiley

    Dr Warrick J Inder